Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 

    Article Cited by others

REVIEW ARTICLE

Quadrivalent human papillomavirus recombinant vaccine: The first vaccine for cervical cancers

Sharma Rashmi, Sharma Chaman Lal

Year : 2007| Volume: 3| Issue : 2 | Page no: 92-95

   This article has been cited by
 
1 Conjugation of HPV16 E7 to cholera toxin enhances the HPV-specific T-cell recall responses to pulsed dendritic cells in vitro in women with cervical dysplasia
Nurkkala, M., Wassén, L., Nordström, I., Gustavsson, I., Slavica, L., Josefsson, A., Eriksson, K.
Vaccine. 2010; 28(36): 5828-5836
[Pubmed]  [Google Scholar]
2 Conjugation of HPV16 E7 to cholera toxin enhances the HPV-specific T-cell recall responses to pulsed dendritic cells in vitro in women with cervical dysplasia
Merja Nurkkala,Lotta Wassén,Inger Nordström,Inger Gustavsson,Lucija Slavica,Agnetha Josefsson,Kristina Eriksson
Vaccine. 2010; 28(36): 5828
[Pubmed]  [Google Scholar] [DOI]
3 Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model
R. GASPARINI,D. AMICIZIA,P. MANFREDI,F. ANSALDI,C. LUCIONI,G. GALLELLI,D. PANATTO
Epidemiology and Infection. 2009; 137(06): 794
[Pubmed]  [Google Scholar] [DOI]
4 Human papillomavirus vaccination: what is the best choice? A comparison of 16 strategies by means of a decisional model
GASPARINI, R. and AMICIZIA, D. and MANFREDI, P. and ANSALDI, F. and LUCIONI, C. and GALLELLI, G. and PANATTO, D.
Epidemiology and Infection. 2009; 137(6): 794-802
[Pubmed]  [Google Scholar]
5 Different spectra of therapeutic vaccine development against HPV infections
Bolhassani, A., Mohit, E., Rafati, S.
Human Vaccines. 2009; 5(10): 671-689
[Pubmed]  [Google Scholar]
6 Vaccines for human papillomavirus infection: A critical analysis
Thappa, D.M., Nath, A.K.
Indian Journal of Dermatology, Venereology and Leprology. 2009; 75(3): 245-254
[Pubmed]  [Google Scholar]
7 Alphavirus-adjuvanted norovirus-like particle vaccines: Heterologous, humoral, and mucosal immune responses protect against murine norovirus challenge
LoBue, A.D., Thompson, J.M., Lindesmith, L., Johnston, R.E., Baric, R.S.
Journal of Virology. 2009; 83(7): 3212-3227
[Pubmed]  [Google Scholar]
8 DNA vaccination and gene therapy: Optimization and delivery for cancer therapy
Bodles-Brakhop, A.M., Draghia-Akli, R.
Expert Review of Vaccines. 2008; 7(7): 1085-1101
[Pubmed]  [Google Scholar]
9 DNA vaccination and gene therapy: optimization and delivery for cancer therapy
Angela M Bodles-Brakhop,Ruxandra Draghia-Akli
Expert Review of Vaccines. 2008; 7(7): 1085
[Pubmed]  [Google Scholar] [DOI]
10 Development of Unilateral Cervical and Supraclavicular Lymphadenopathy After Human Papilloma Virus Vaccination
James Studdiford,Kathleen Lamb,Kedron Horvath,Marc Altshuler,Amber Stonehouse
Pharmacotherapy. 2008; 28(9): 1194
[Pubmed]  [Google Scholar] [DOI]
11 Development of Unilateral Cervical and Supraclavicular Lymphadenopathy After Human Papilloma Virus Vaccination
Studdiford, J. and Lamb, K. and Horvath, K. and Altshuler, M. and Stonehouse, A.
Pharmacotherapy. 2008; 28(9): 1194-1197
[Pubmed]  [Google Scholar]

 

Read this article